Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction - Slideshow (NASDAQ:IONS) 2026-06-25

技术访问问题 - 用户浏览器需启用Javascript和cookies以正常访问内容 [1] - 启用广告拦截器可能导致访问被阻止,需禁用并刷新页面 [1]

Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval of TRYNGOLZA for Severe Hypertriglyceridemia and Acute Pancreatitis Risk Reduction - Slideshow (NASDAQ:IONS) 2026-06-25 - Reportify